Opko Health, Inc.
OPK
$1.29
-$0.015-1.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.66% | 0.95% | -2.78% | -31.36% | -26.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.66% | 0.95% | -2.78% | -31.36% | -26.89% |
| Cost of Revenue | -10.02% | -17.36% | 7.93% | -1.58% | -10.16% |
| Gross Profit | -41.49% | 114.25% | -59.78% | -74.55% | -69.80% |
| SG&A Expenses | -15.79% | -8.03% | 35.94% | -13.75% | -7.24% |
| Depreciation & Amortization | -7.35% | -5.33% | -5.11% | -5.18% | -0.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.44% | -13.62% | 15.07% | -5.64% | -8.54% |
| Operating Income | 6.02% | 52.01% | -63.70% | -982.13% | -134.66% |
| Income Before Tax | 11.78% | 148.24% | 161.76% | 35.82% | -388.35% |
| Income Tax Expenses | -327.41% | 448.00% | 287.28% | -108.89% | -209.49% |
| Earnings from Continuing Operations | 17.38% | 121.10% | 129.47% | 47.53% | -348.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.38% | 121.10% | 129.47% | 47.53% | -348.00% |
| EBIT | 6.02% | 52.01% | -63.70% | -982.13% | -134.66% |
| EBITDA | 4.32% | 78.88% | -111.97% | -211.86% | -1,037.89% |
| EPS Basic | 13.04% | 123.39% | 131.85% | 43.30% | -376.54% |
| Normalized Basic EPS | 9.51% | 273.44% | -80.91% | 196.43% | -425.71% |
| EPS Diluted | 13.04% | 119.28% | 128.29% | 43.30% | -376.54% |
| Normalized Diluted EPS | 9.51% | 223.31% | -25.84% | 196.43% | -425.71% |
| Average Basic Shares Outstanding | -4.99% | -9.94% | -7.57% | -7.25% | -5.94% |
| Average Diluted Shares Outstanding | -4.99% | 26.66% | 32.85% | -7.25% | -5.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |